Saccharomyces cerevisiae β-Carbonic Anhydrase: Inhibition and Activation Studies

被引:20
|
作者
Isik, Semra [3 ]
Guler, Ozen Ozensoy [3 ]
Kockar, Feray [1 ]
Aydin, Meltem [1 ]
Arslan, Oktay [3 ]
Supuran, Claudiu T. [2 ]
机构
[1] Balikesir Univ, Sci & Art Fac, Dept Biol, Balikesir, Turkey
[2] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[3] Balikesir Univ, Sci & Art Fac, Dept Chem, Balikesir, Turkey
关键词
Carbonic anhydrase; beta-class enzyme; Saccharomyces cerevisiae; yeast; sulfonamide; sulfamate; anion inhibitor; amino acid; amine; activator; PATHOGENS CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; CRYSTALLOGRAPHIC ANALYSIS; CLASS ENZYMES; ACTIVE-SITE; GENE NCE103; ISOFORM-II; ISOZYME-II; CLASS CAB; CO2;
D O I
10.2174/138161210793429878
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta-carbonic anhydrase from Saccharomyces cerevisiae (CA, EC 4.2.1.1), scCA, which is encoded by the Nce103 gene, is an effective catalyst for CO2 hydration to bicarbonate and protons, with a k(cat) of 9.4 x 10(5) s(-1), and k(cat)/K-M of 9.8 x 10(7) M-1.s(-1). Its inhibition with anions and sulfonamides has been investigated, as well as its activation with amines and amino acids. Bromide, iodide and sulfamide, were the best anion inhibitors, with K(I)s of 8.7 - 10.8 mu M. Benzenesulfonamides substituted in 2-, 4- and 3,4-positions with amino, alkyl, halogeno and hydroxyalkyl moieties had K(I)s in the range of 0.976 - 18.45 mu M. Better inhibition (K(I)s in the range of 154 654 nM) was observed for benzenesulfonamides incorporating aminoalkyl/carboxyalkyl moieties or halogenosulfanilamides; benzene-1,3-disulfonamides; simple heterocyclic sulfonamides and sulfanilyl-sulfonamides. The clinically used sulfonamides/sulfamate (acetazolamide, ethoxzolamide, methazolamide, dorzolamide, topiramate, celecoxib, etc.) generally showed effective scCA inhibitory activity, with K(I)s in the range of 82.6 - 133 nM. The best inhibitor (K-I of 15.1 nM) was 4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide. L-adrenaline and some piperazines incorporating aminoethyl moieties were the most effective scCA activators. These studies may lead to a better understanding of the role of this enzyme in yeasts/fungi, and since the Nce103 gene is also present in many pathogenic organisms (Candida spp., Cryptococcus neoformans, etc) they may be useful to develop antifungal drugs.
引用
收藏
页码:3327 / 3336
页数:10
相关论文
共 50 条
  • [1] Carbonic anhydrase activators: Activation of the β-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amines and amino acids
    Isik, Semra
    Kockar, Feray
    Aydin, Meltem
    Arslan, Oktay
    Guler, Ozen Ozensoy
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1662 - 1665
  • [2] Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates
    Isik, Semra
    Kockar, Feray
    Aydin, Meltem
    Arslan, Oktay
    Guler, Ozen Ozensoy
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (03) : 1158 - 1163
  • [3] Carbonic anhydrase inhibitors. Inhibition of the β-class enzyme from the yeast Saccharomyces cerevisiae with anions
    Isik, Semra
    Kockar, Feray
    Arslan, Oktay
    Guler, Ozen Ozensoy
    Innocenti, Alessio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) : 6327 - 6331
  • [4] Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase
    Alafeefy, Ahmed M.
    Isik, Semra
    Al-Jaber, Nabila A.
    Vullo, Daniela
    Abdel-Aziz, Hatem A.
    Ashour, Abdelkader E.
    Awaad, Amani S.
    Capasso, Clemente
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (12) : 3570 - 3575
  • [5] Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase
    Bozdag, Murat
    Carta, Fabrizio
    Vullo, Daniela
    Isik, Semra
    AlOthman, Zeid
    Osman, Sameh M.
    Scozzafava, Andrea
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (01) : 132 - 136
  • [6] Inhibition of carbonic anhydrase
    Merz, Kenneth M.
    Murcko, Mark A.
    Kollman, Peter A.
    Journal of the American Chemical Society, 1992, 114 (03):
  • [7] CARBONIC ANHYDRASE INHIBITION
    SIMPSON, T
    LANCET, 1955, 1 (APR30): : 920 - 920
  • [8] INHIBITION OF CARBONIC ANHYDRASE
    MARTIN, GJ
    BALANT, CP
    AVAKIAN, S
    BEILER, JM
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1954, 98 (03): : 284 - 287
  • [9] CARBONIC ANHYDRASE INHIBITION .7. CARBONIC ANHYDRASE INHIBITION AND ANTICONVULSANT EFFECT
    GRAY, WD
    MAREN, TH
    SISSON, GM
    SMITH, FH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1957, 121 (02): : 160 - 170
  • [10] Structural insights into the substrate tunnel of Saccharomyces cerevisiae carbonic anhydrase Nce103
    Teng, Yan-Bin
    Jiang, Yong-Liang
    He, Yong-Xing
    He, Wei-Wei
    Lian, Fu-Ming
    Chen, Yuxing
    Zhou, Cong-Zhao
    BMC STRUCTURAL BIOLOGY, 2009, 9